welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
terminated
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
status: terminated
purpose:Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
intervention:
Drug: Rofecoxib
Drug: placebo
study details
study contacts
expertly curated content related to this topic
-
The Genetics of Familial Adenomatous Polyposis (FAP) and MutYH-Associated Polyposis (MAP)FAP is characterized by 100-1000s of ade...
-
Familial Adenomatous Polyposis and Desmoid TumorsFamilial adenomatous polyposis (FAP) is ...
-
Starch Powder That can be Sprinkled on Food is Tested as Cure for Bowel CancerA powder made from starch that can b...
-
Familial Polyposis: Stomach (Dr. Riegert-Johnson)https://www.youtube.com/watch?v=qCEFpBIR...
-
Cell Proliferation and Apoptotic Indices Predict Adenoma Regression in a Placebo-Controlled Trial of Celecoxib in Fa...BACKGROUND : Celecoxib was shown to regr...
-
Clinical Management of Hereditary Colorectal Cancer SyndromesHereditary factors are involved in the d...
-
Intestinal Polyps and Polyposis: State-of-the-Art, Multidisciplinary Publication on Polyps and PolyposisNowadays, we are dealing more frequently...